Document Detail


Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women.
MedLine Citation:
PMID:  18029465     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: Recent studies disputed the widely promoted anti-aging effect of dehydroepiandrosterone (DHEA) supplementation; however, conflicting data exist on whether physiological DHEA supplementation enhances exercise training effects on body composition, physical performance, and cardiometabolic risk in healthy postmenopausal women. OBJECTIVE: The aim of this study was to determine whether 12 wk of DHEA supplementation (50 mg/d) in postmenopausal women enhances exercise-related changes in body composition, physical performance, and cardiometabolic risk. DESIGN AND SETTING: This study was a 12-wk randomized double-blind, placebo-controlled trial and took place at the Mayo Clinic General Clinical Research Center (Rochester, MN). PARTICIPANTS: Thirty-one sedentary, postmenopausal, Caucasian women (mean +/- sem age 64.6 +/- 1.0 yr) completed the study. INTERVENTION: Participants were randomized to one of two 12-wk interventions: 1) exercise training plus 50 mg/d of DHEA (n = 17), or 2) exercise training plus placebo (n = 14). The exercise intervention consisted of both endurance (4 d/wk) and resistance (3 d/wk) exercise components. MAIN OUTCOME MEASURES: The main outcomes were measures of body composition, physical performance, and measures of cardiometabolic risk. RESULTS: DHEA treatment with exercise resulted in increases in circulating sulfated DHEA (650%), total testosterone (100%), estradiol (165%), estrone (85%), and IGF-I (30%) (all P < or = 0.05, for all within and between treatment comparisons). Although exercise training alone significantly improved physical performance, body composition, and insulin sensitivity, administration of DHEA provided no additional benefits. CONCLUSIONS: Twelve weeks of combined endurance and resistance training significantly improved body composition, physical performance, insulin sensitivity, and low-density lipoprotein cholesterol particle number and size, whereas DHEA had no additional benefits.
Authors:
Ada Igwebuike; Brian A Irving; Maureen L Bigelow; Kevin R Short; Joseph P McConnell; K Sreekumaran Nair
Related Documents :
21606845 - Incremental exercise using progressive versus constant pedaling rates: a study in cardi...
15640395 - Leptin gene expression and systemic levels in healthy men: effect of exercise, carbohyd...
6485145 - Decrease in body insulation with exercise in cool water.
3503255 - Effects of endurance training on body-consciousness in women.
19450365 - Primary prevention of cvd: physical activity.
17317135 - Exercise capacity and exercise-induced bronchoconstriction (eib) in a cold environment.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural     Date:  2007-11-20
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  93     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-02-08     Completed Date:  2008-04-10     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  534-8     Citation Subset:  AIM; IM    
Affiliation:
Division of Endocrinology, Endocrine Research Unit, Mayo Clinic, 200 First Street SW, Joseph 5-194, Rochester, Minnesota 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Blood Glucose / metabolism
Body Composition / drug effects,  physiology
Cholesterol / blood
Dehydroepiandrosterone / blood,  pharmacology*
Dehydroepiandrosterone Sulfate / blood
Double-Blind Method
Estradiol / blood
Estrone / blood
Female
Glucose Clamp Technique
Humans
Insulin Resistance / physiology
Insulin-Like Growth Factor I / metabolism
Middle Aged
Physical Endurance / drug effects*,  physiology
Physical Fitness / physiology*
Postmenopause / blood,  physiology*
Testosterone / blood
Triglycerides / blood
Grant Support
ID/Acronym/Agency:
1 UL1 RR24150-01/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Triglycerides; 50-28-2/Estradiol; 53-16-7/Estrone; 53-43-0/Dehydroepiandrosterone; 57-88-5/Cholesterol; 58-22-0/Testosterone; 651-48-9/Dehydroepiandrosterone Sulfate; 67763-96-6/Insulin-Like Growth Factor I
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessment of the magnitude of growth hormone hypersecretion in active acromegaly: reliability of di...
Next Document:  Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid di...